Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.
Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.
Curr Opin Immunol. 2018 Apr 19;53:51-57
Authors: Nachbagauer R, Palese P
Abstract
Influenza viruses are a severe threat to human health and current vaccines do not provide sufficient protection. The highly variable nature of influenza viruses has made the production of efficacious vaccines a challenge. In recent years, a multitude of novel, broadly reactive influenza virus vaccination approaches have been described. What has long seemed impossible could now become reality in the near future-a new generation of influenza virus vaccines that provides long-lasting and broad protection against seasonal as well as potentially pandemic influenza virus strains. This review will discuss new hemagglutinin-based vaccines and their current stage of development.
PMID: 29680576 [PubMed - as supplied by publisher]
Source: Current Opinion in Immunology - Category: Allergy & Immunology Authors: Nachbagauer R, Palese P Tags: Curr Opin Immunol Source Type: research
More News: Allergy & Immunology | Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Flu Pandemic | Influenza | Influenza Vaccine | Pandemics | Vaccines